Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: excite (79), inspire (52), motivate (59)

Your child's medication: Methylphenidate for narcolepsy - patient information

Description: This factsheet explains how your child should take methylphenidate as part of their treatment programme for narcolepsy.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-medication-Methylphenidate-for-narcolepsy-3755-PIL.pdf

Your child's medication: Dexamfetamine for narcolepsy - patient information

Description: This factsheet explains how your child should take dexamfetamine as part of their treatment programme for narcolepsy.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-medication-Dexamfetamine-for-narcolepsy-3756-PIL.pdf

What to expect in the early stage of labour - patient information

Description: This factsheet has been designed to give you information about what to expect and how to look after yourself during the
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/What-to-expect-in-the-early-stage-of-labour-1035-PIL.pdf

Talimogene laherparepvec (T-VEC)

Description: Chemotherapy Protocol SKIN CANCER Talimogene laherparepvec (T-VEC) Regimen • Skin – Talimogene laherparepvec (T-VEC) Indication • Talimogene laherparepvec (T-VEC) is recommended
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Talimogene-laherparepvec-T-VEC.pdf

Azacitidine Oral

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA -AZACITADINE (ORAL) Regimen • AML – AZACITADINE (ORAL) Indication Oral azacitidine as maintenance therapy in newly diagnosed AML
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine-Oral.pdf

Build yourself up - patient information

Description: This leaflet is a guide to 'building yourself up' through your diet and eating habits.
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Build-yourself-up-1841-PIL.pdf

Cisplatin Doxorubicin Methotrexate Vinblastine (accelerated) ver1.1

Description: Chemotherapy Protocol BLADDER CISPLATIN-DOXORUBICIN-METHOTREXATE-VINBLASTINE (Accelerated MVAC) Regimen Bladder-Cisplatin-Doxorubicin-Methotrexate-Vinblastine (AccMVAC) Indication First or second line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-Doxorubicin-Methotrexate-Vinblastine-accelerated-ver1.1.pdf

Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant therapy for node positive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf

Lenvatinib

Description: Chemotherapy Protocol THYROID CANCER LENVATINIB Regimen • Thyroid – Lenvatinib Indication • The treatment of differentiated thyroid cancer after radioactive iodine where all the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Lenvatinib.pdf

Belantamab Bortezomib Dexamethasone Weekly

Description: Chemotherapy Protocol BELANTAMAB MAFODOTIN – BORTEZOMIB - DEXAMETHASONE This protocol may require funding Regimen • Belantamab Mafodotin – Bortezomib - Dexamethasone Indication • 1 previous line of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Belantamab-Bortezomib-Dexamethasone-Weekly-Ver1.pdf

81 to 90 of 104

Previous … 7 8 9 10 11 Next